DexCom Stock-Based Comp increased by 23.7% to $43.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 26.6%, from $34.20M to $43.30M. Over 4 years (FY 2021 to FY 2025), Stock-Based Comp shows an upward trend with a 8.9% CAGR.
Increasing levels may indicate a focus on talent retention but can also signal potential shareholder dilution.
This represents the value of equity-based awards granted to employees as part of their total compensation package. Since...
Standard across large-cap corporations; varies based on corporate compensation philosophy.
stock_based_compensation| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $31.60M | $27.50M | $26.30M | $29.10M | $32.60M | $30.80M | $34.00M | $35.20M | $39.70M | $39.00M | $36.90M | $39.00M | $44.70M | $43.40M | $43.30M | $34.20M | $45.30M | $45.10M | $35.00M | $43.30M |
| QoQ Change | — | -13.0% | -4.4% | +10.6% | +12.0% | -5.5% | +10.4% | +3.5% | +12.8% | -1.8% | -5.4% | +5.7% | +14.6% | -2.9% | -0.2% | -21.0% | +32.5% | -0.4% | -22.4% | +23.7% |
| YoY Change | — | — | — | — | +3.2% | +12.0% | +29.3% | +21.0% | +21.8% | +26.6% | +8.5% | +10.8% | +12.6% | +11.3% | +17.3% | -12.3% | +1.3% | +3.9% | -19.2% | +26.6% |